Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when BioAge Labs, Inc. publishes a filing, an earnings call transcript or a press release.

Get BIOA alerts

About Paul Rubin

The proxy statement of BioAge Labs, Inc. reports total compensation of $1,476,080 for Paul Rubin in fiscal 2025, including a base salary of $520,200. Disclosed compensation is on record for 3 fiscal years. Paul Rubin has spoken on 1 earnings call across 1 company, most recently for BioAge Labs, Inc. on April 21, 2026. BioAge Labs, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at BioAge Labs, Inc. includes Kristen Fortney (CEO), Dov Goldstein (CFO) and Eric Morgen (COO).

Paul Rubin on recent calls

“I'll start with the overall trial design and key objectives, and then I'll move into the detailed results. Next slide.”
Other, BioAge Labs, Inc. Q1 FY2026 Earnings Call ·

Affiliation history

Company network

Leadership on record at BioAge Labs, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 BioAge Labs, Inc. (BIOA) $520,200 $1,476,080
2024 BioAge Labs, Inc. (BIOA) $488,139 $1,923,841
2023 BioAge Labs, Inc. (BIOA) $468,939 $836,762

Recent activity